Recombinant multi-species CCL27 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL27 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The protein encoded by this gene is chemotactic for skin-associated memory T lymphocytes. This cytokine may also play a role in mediating homing of lymphocytes to cutaneous sites. It specifically binds to chemokine receptor 10 (CCR10). Studies of a similar murine protein indicate that these protein-receptor interactions have a pivotal role in T cell-mediated skin inflammation. [provided by RefSeq, Sep 2014]
The Alternative Names of target: ALP,C-C motif chemokine 27,CC chemokine ILC,CCL27,CTACK,CTAK,Ccl27,Ccl27a,Cutaneous T-cell-attracting chemokine (CTACK),ESKINE,ESkine,IL-11 R-alpha-locus chemokine,ILC,PESKY,SCYA27,Scya27,Scya27a,Skinkine,Small-inducible cytokine A27

Target products collectionGo to CCL27 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0747-Ag-1/ GM-Tg-hg-SE0747-Ag-2 Human CCL27 protein Human
GM-Tg-rg-SE0747-Ag-1/ GM-Tg-rg-SE0747-Ag-2 Rat CCL27 protein Rat
GM-Tg-mg-SE0747-Ag-1/ GM-Tg-mg-SE0747-Ag-2 Mouse CCL27 protein Mouse
GM-Tg-cynog-SE0747-Ag-1/ GM-Tg-cynog-SE0747-Ag-2 Cynomolgus/Rhesus macaque CCL27 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0747-Ag-1/ GM-Tg-felg-SE0747-Ag-2 Feline CCL27 protein Feline
GM-Tg-cang-SE0747-Ag-1/ GM-Tg-cang-SE0747-Ag-2 Canine CCL27 protein Canine
GM-Tg-bovg-SE0747-Ag-1/ GM-Tg-bovg-SE0747-Ag-2 Bovine CCL27 protein Bovine
GM-Tg-equg-SE0747-Ag-1/ GM-Tg-equg-SE0747-Ag-2 Equine CCL27 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0747-Ag-1/ GM-Tg-hg-SE0747-Ag-2; GM-Tg-rg-SE0747-Ag-1/ GM-Tg-rg-SE0747-Ag-2;
GM-Tg-mg-SE0747-Ag-1/ GM-Tg-mg-SE0747-Ag-2; GM-Tg-cynog-SE0747-Ag-1/ GM-Tg-cynog-SE0747-Ag-2;
GM-Tg-felg-SE0747-Ag-1/ GM-Tg-felg-SE0747-Ag-2; GM-Tg-cang-SE0747-Ag-1/ GM-Tg-cang-SE0747-Ag-2;
GM-Tg-bovg-SE0747-Ag-1/ GM-Tg-bovg-SE0747-Ag-2; GM-Tg-equg-SE0747-Ag-1/ GM-Tg-equg-SE0747-Ag-2
Products Name CCL27 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCL27
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL27 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.